Kılıçkap, S.Öztürk, A.Karadurmuş, N.Korkmaz, T.Yumuk, P.Cicin, I.Paydaş, S.Cilbir, E.Sakalar, T.Uysal, M.Uskent, N.Demir, N.Sakin, A.Turhal, N.Keskin, S.Tural, D.Eralp, Y.Basal, F.Yaşar, H.Sendur, M. A.Demirci, U.Çubukcu, ErdemKaraağaç, M.Karaca, S.Tatlı, A.Yetişyiğit, T.Urvay, S.Gürsoy, P.Uluc, B. OyanTurna, Z.Küçükoner, M.Çlmez, O.Çabuk, D.Şeker, M.Ünal, O.Meydan, N.Okutur, S.Tunalı, D.2024-07-252024-07-252018-10-011556-0864https://hdl.handle.net/11452/43443eninfo:eu-repo/semantics/closedAccessNsclcAlk inhibitorCrizotinibScience & technologyLife sciences & biomedicineRespiratory systemOncologyMeeting Abstract000454014501235S477S47813101556-1380